Cancel
Joanna Brewer, Ph.D.
Chief Scientific Officer
@
Adaptimmune
About Joanna Brewer, Ph.D.
Joanna Brewer, Ph.D., is the Chief Scientific Officer at Adaptimmune, known for her pivotal role in advancing allogeneic T-cell therapies and building the Allogeneic Research organization.
Known information
Joanna Brewer, Ph.D., serves as the Chief Scientific Officer at Adaptimmune, where she has been instrumental in developing innovative T-cell therapies. Holding a master’s degree in Natural Sciences and a Ph.D. in cellular signalling from the University of Cambridge, U.K., Brewer has a strong background in cellular biology. She joined Adaptimmune in December 2019 as Senior Vice President of Allogeneic Research and was responsible for building the Allogeneic Research organization from scratch. Under her leadership, the concept of iPSC-derived allogeneic T-cell therapies was developed from an initial idea to a potential clinical candidate. Prior to her current role, Brewer was one of the founding scientists at Adaptimmune, where she established multiple research teams focused on the development of SPEAR T-cell therapies. Her earlier career includes significant positions at Avidex, Medigene, and Immunocore, contributing to her extensive experience in the biotechnology field.
About Adaptimmune
Adaptimmune is a biotechnology company specializing in the development of T-cell-based therapies for cancer treatment, with a focus on engineering patients' own cells to combat solid tumors.
Report inaccurate information
